4
Changes in Ownership
Lexeo Therapeutics, Inc. Filed Acc 0001415889-25-022468
Chief Development Officer sold 382 shares at $4.67 ($1,783)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| See Tai Sandi Chief Development Officer | 2025-08-18 | Sale | −382 | $4.67 | $1,783 | 58,860 | D: show line 1 in the form |
| Open-market sales · 382 sh · avg $4.67 · $1,783 | |||||||
Loading xslF345X05/form4-08202025_080818.xml…